Detalhe da pesquisa
1.
Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective analysis.
Ann Med
; 56(1): 2317356, 2024 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38364218
2.
SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen.
Trials
; 24(1): 435, 2023 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37370174